Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06813495 · ClinicalTrials.gov registry record · NA

Eastern Principles Acceptance and Commitment Therapy For Injury Prevention Among Nurses and Nursing Aides

A NA study of Musculoskeletal Pain and Well-Being, Psychological, sponsored by Bowling Green State University.

Recruiting
Registry status
NA
Development phase
255
Enrollment target
1
Study location

NCT06813495: Recruiting NA study of Musculoskeletal Pain and Well-Being, Psychological, sponsored by Bowling Green State University.

NCT06813495 is a NA study of Musculoskeletal Pain and Well-Being, Psychological that is actively recruiting participants, run by Bowling Green State University. The registered enrollment target is 255 participants, above the 149-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (71% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06813495, a NA study of Musculoskeletal Pain and Well-Being, Psychological, is actively recruiting participants, sponsored by Bowling Green State University.

RECRUITING
Registry status
NA
Development phase
255 participants
Enrollment target
1
Study location

Study Summary

This clinical trial will evaluate the effectivness of an Eastern Principles Acceptance and Commitment Therapy intervention (EPACT) relative to an estabished traditional Western-based Acceptance and Commitment Therapy intervention (ACT) and a no treatment control group. The participants for the study will be nurses and nursing aides (NNAs) who work in long-term care settings in the USA and Thailand. The primary dependent variables are work-related injuries, work stress and burnout, wellbeing, musculoskeletal symptoms, time off from work due to injury. High frequency heart rate variability will also be investigated as a predictor of responsiveness to the interventions. The study has three primary aims: 1. To compare the EPACT NNA intervention to an established traditional Western ACT NNA intervention and a no-treatment control group. 2. To identify predictors of ACT NNA and EPACT NNA responsiveness to the interventions and injury likelihood across time. 3. To assess EPACT NNA's feasibility and effectiveness across cultures. USA participants working in Ohio will be randomly assigned to one of three groups: EPACT NNA (n = 80), ACT NNA (n = 80), or a no treatment control group (n = 80). All participants will participate in an assessment session where study questnnaires are completed and a baseline high frequency HRV measurement is collected. Subsequent to the assessment, the EPACT NNA and ACT NNA participants will attend two 2.5 hour sessions spaced one week apart. The control group will have no further in-person meetings with the researchers. One-month after completing the intervention (4 weeks after the baseline assessment) a follow-up survey will be sent to participants for the first follow-up. Three months after baseline, the second follow-up survey will be sent to participants. The surveys assess demographic characteristics, organizational variables, work-related injuries, work stress, and well-being. A second RCT study will be conducted in Thailand comparing E

Primary Outcome

The Risk for Nursing Aide Injury Inventory (RNAII) contains 6 items measuring demographic variables, 9 items measuring job characteristics (e.g., tenure, hours per week, hours per shift, etc.) and 120 items assessing individual and organizational characteristics (e.g., staffing, space, training, physical environment characteristics, organizational constraints, incivility, family-work conflict, lifting device availability, organizational safety climate, supervisor relationships, and worker respec

Interventions

  • BEHAVIORAL Eastern Principles Acceptance and Commitment Therapy for Nurses and Nursing Aids (EPACT NNA)
  • BEHAVIORAL Acceptance and Commitment Therapy for Nurses and Nursing Aids (ACT NNA)

Study Locations (1)

Ohio

  • Bowling Green State University - Bowling Green

Trial Details

FieldValue
Enrollment Target 255 participants
Start Date 2023-05-01
Est. Completion 2026-05-01
Phase NA
Bowling Green State University

1 total trials

What NCT06813495 shows while recruiting

NCT06813495 is an interventional study that assigns participants to a tested intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, above the 149-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (71% higher).

The record links to 9 conditions, with Musculoskeletal Pain appearing as the primary indexed condition, and to 2 interventions - of which Eastern Principles Acceptance and Commitment Therapy for Nurses and Nursing Aids (EPACT NNA) is the first listed.

NCT06813495 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06813495 about?

NCT06813495 is a clinical study titled "Eastern Principles Acceptance and Commitment Therapy For Injury Prevention Among Nurses and Nursing Aides". This clinical trial will evaluate the effectivness of an Eastern Principles Acceptance and Commitment Therapy intervention (EPACT) relative to an estabished traditional Western-based Acceptance and Commitment Therapy intervention (ACT) and a no treatment control group. The participants for the study...

What is the current status of trial NCT06813495?

This trial is currently recruiting. It is a NA study. The enrollment target is 255 participants. The study started on 2023-05-01. Estimated completion is 2026-05-01.

What conditions does trial NCT06813495 study?

This clinical trial studies the following conditions: Musculoskeletal Pain, Well-Being, Psychological, Burnout, Mindfulness, Self-Compassion.

What interventions are being tested in trial NCT06813495?

The interventions under investigation include: Eastern Principles Acceptance and Commitment Therapy for Nurses and Nursing Aids (EPACT NNA) (BEHAVIORAL), Acceptance and Commitment Therapy for Nurses and Nursing Aids (ACT NNA) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06813495?

This trial is sponsored by Bowling Green State University, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06813495 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Musculoskeletal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06813495's enrollment target sits among peer trials

255 11th of 37 higher than 27 of 37 other Musculoskeletal Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Musculoskeletal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04623424 · 255 participants

    Intestinal Microbiota in Stem Cell Transplant Transplant Admission

  • NCT05114798 · 255 participants · NA

    Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

  • NCT05336188 · 255 participants · Phase 2

    Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

  • NCT05486637 · 255 participants · Early Phase 1

    Vocal Emotion Communication With Cochlear Implants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06813495, the US trial registry maintained by the National Library of Medicine. NCT06813495 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.